PharmaResources (Shanghai) Co. Ltd. A (301230) — Free Cash Flow Generation Index

Latest as of December 2025: 0.68x

PharmaResources (Shanghai) Co. Ltd. A (301230) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of CN¥92.20 Million represents 1% of operating cash flow (CN¥135.51 Million). See 301230 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.68x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥92.20 Million
CNY

Operating Cash Flow

CN¥135.51 Million
CNY

Capital Expenditures

CN¥43.32 Million
CNY

PharmaResources (Shanghai) Co. Ltd. A Free Cash Flow Generation Index (2020–2025)

Historical FCF Generation Index trend for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Explore PharmaResources (Shanghai) Co. Ltd. A (301230) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)

Year-by-year Free Cash Flow Generation Index for PharmaResources (Shanghai) Co. Ltd. A. For the full company profile including market capitalisation, see market cap of PharmaResources (Shanghai) Co. Ltd. A.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.68x CN¥92.20 Million CN¥135.51 Million CN¥43.32 Million ▲ +292.8%
2024 -0.35x CN¥-28.54 Million CN¥80.86 Million CN¥109.40 Million ▲ +96.8%
2023 -10.90x CN¥-227.41 Million CN¥20.86 Million CN¥248.27 Million ▼ -4288.0%
2022 -0.25x CN¥-24.67 Million CN¥99.29 Million CN¥123.97 Million ▼ -300.8%
2021 0.12x CN¥13.01 Million CN¥105.12 Million CN¥92.12 Million ▼ -67.8%
2020 0.38x CN¥20.94 Million CN¥54.45 Million CN¥33.51 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).